Bavarian biotechnology grows and achieves record financing

11 start-ups and two relocations show start-up momentum

09-Jul-2024 - At this year's BayOConnect conference, BioM presented his latest annual report "Biotech in Bavaria 2023/24 - Incubating Science for Health". With the report, the Biotech Cluster Development Organization presented the current biotech figures as well as developments and successes of the Bavarian ...

Life Sciences organizations expect more than one-fifth of revenue to come from connected health in the next five years

Generative AI has the potential to add value throughout the healthcare value chain

21-Jun-2024 - The majority (63%) of life sciences organizations, across biopharma and medtech, have connected health products already on the market or under development. Irrespective of their stage of product development, life sciences organizations anticipate that connected health will contribute more than ...

Merck Announces Collaboration with Agilent Technologies

Collaboration will help enable real-time release and Bioprocessing 4.0

15-Jun-2022 - Merck announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0. “The biopharmaceutical industry is on a ...

Merck to Expand US Biopharmaceutical R&D Facility

Merck investing $70 million in U.S. Research & Development Hub

07-Feb-2019 - Merck announced a $70 million investment to expand its state of the art research and development (R&D) facility in Billerica, Massachusetts. The new building will span 145,000 square feet, offering new laboratory and collaborative working space to accommodate approximately 400 new and current R&D ...

Lanthio Pharma expands management team

20-Sep-2016 - The Dutch biopharmaceutical company Lanthio Pharma B.V., a wholly owned subsidiary of MorphoSys AG, announced the appointment of Axel Mescheder, M.D. as Chief Medical Officer (CMO). Dr. Heinz Schwer, Chief Executive Officer of Lanthio Pharma, commented: "We are very pleased to welcome Axel ...

Merck announces survey results exploring Biopharma Industry’s evolving risk model

New approaches for mitigating risk associated with new growth strategies

09-Jun-2016 - Merck announced survey results of 250 global biopharmaceutical executives on how their companies will manage new risks associated with the changing biopharma landscape. The survey, sponsored by Merck, was conducted by the Economist Intelligence Unit (EIU), a leading resource for economic and ...

Sartorius Reviews Fiscal 2013 Results

05-Mar-2014 - The Sartorius Group closed fiscal 2013 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Group CEO Dr. Joachim Kreuzburg emphasized that the company not only achieved all financial targets, but also has successfully moved forward with its ...